NCT00600301|WithdrawnPhase 3
Study Stopped
undefined
Loading search results
Sponsor study identifier
interventional
0
1 country
1
Study Start
January 2008
Actual (reported)Primary Completion
January 2008
Actual (reported)Study Completion
January 2008
Actual (reported)Diabetic macular edema is the most common cause of visual loss among patients with diabetic retinopathy. Pars plana vitrectomy has been reported to be effective for the treatment of diabetic macular edema. Previous report showed a limited improvement in visual acuity and macular thickness posterior intraoperative triamcinolone acetonide. Bevacizumab intravitreal injection has been proven be effective in the treatment of diabetic macular edema, in recent publications. The purpose of this study is to evaluate whether vitrectomy with and without intravitreal triamcinolone acetonide and bevacizumab injection affects vision outcome and macular thickness in patients with diabetic macular edema.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
January 2008
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
June 30, 2006
Actual (reported)January 2008
Actual (reported)January 2008
Actual (reported)January 2008
Actual (reported)January 24, 2008
Actual (reported)Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
These entries preserve how the registry describes the intervention. Their treatment roles are shown separately from molecular identities.
Grouped treatment entry
Triamcinolone Acetonide and Bevacizumab
The registry names several treatments. This does not confirm that participants received them together or that they form a single product.
View registry recordAsociacion Para Evitar la Ceguera en Mexico
México, 04030, Mexico
Maximiliano Gordon, MD
Asociación para Evitar la Ceguera en México
0 participants (actual enrollment reported by the registry).
First Submitted
June 30, 2006
First Posted
January 24, 2008
Study Start
January 2008
Actual (reported)Intravitreal Diclofenac Versus Avastin as Primary Treatment of Diffuse Diabetic Macular Edema
Contact the study team to confirm eligibility.
Primary Completion
January 2008
Actual (reported)Study Completion
January 2008
Actual (reported)Last Updated
May 30, 2024
Record last verified: 2024-05
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: